[1] |
FANG Liaoxin, KANG Xiaofeng, XUE Chunyuan, PAN Lu, CHEN Jiaxin, TANG Chuanhao, SUN Liying, XU Xiaojie, DU Yimeng .
Effects of Omicron variant XBB.. spike protein on biological function of human non-small cell lung cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 271-276.
|
[2] |
LI Nan, LU Chenyang, ZHU Ani, YANG Dongcai, MA Qian, YAN Fengqi, JIA Weihong.
Effects of glycolysis in Gefitinib resistance in non⁃small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 50-55.
|
[3] |
QIU Haiping, XIE Xiaoping, CHEN Tianqing.
A trend analysis of the incidence and mortality of lung cancer and an age-period-cohort model in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 537-542.
|
[4] |
LIU Huaying, XIA Xue, ZHANG Mengwei, LUO Qinqin.
Bisdemethoxycurcumin induces apoptosis and inhibits proliferation of non-small cell lung cancer cells by regulating HIF-1α-mediated senescence
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 291-297.
|
[5] |
GONG Jingjie, ZHANG Haibo, YANG Yi, CAO Jiayu, DING Nan, ZHAO Jun.
Influencing factors of quality of life in patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 322-327.
|
[6] |
JIA Xiaoqiong, SUN Qiuying, LIU Xiaoyu, WEN Zhenping.
miR⁃449a regulates proliferation and apoptosis of non⁃small cell lung cancer cells through NOTCH1⁃mediated ferroptosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 617-623.
|
[7] |
WU Min, JIN Mengmeng, CAO Xiaohui, Li Yonghuai.
Effect of combining anlotinib with gefitinib on proliferation of non⁃small cell lung cancer PC9/GR cells and its possible mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 503-508.
|
[8] |
TANG Chao, LI Jianmin, PAN Chanyuan, TAN Wenwen, LIU Hui.
Correlation of miR-7 and SP-1 with radiotherapy sensitivity in NSCLC patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 647-652.
|
[9] |
ZHANG Weiming, LIU Zhibing, WANG Wen, LAN Weiguang, MA Longbo, WANG Feng.
Effect of DLC-1 overexpression on proliferation and invasion of non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 258-262.
|
[10] |
MENG Dongxue, GUO Yurong, LUO Binjun, ZHOU Xinhua, FU Yao, CAO Tianxiong.
Fuzheng Yiliu decoction inhibits the proliferation,apoptosis and autophagy of non?small cell lung cancer through PI3K/Akt/mTOR signaling pathway
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(2): 177-182.
|
[11] |
XIA Yu, ZENG Min, JIA Bin, SUN Feng, LIU Xuemei, WANG Haiyue.
Effect of GATA4 gene methylation on the growth of non-small cell lung cancer and underlying mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(6): 657-664.
|
[12] |
YU Yuanyuan, LEI Huaiding, WU Chenglin, ZHAO Su, WANG Meifang.
Influence of miR-572 on the malignant biological behavior of lung cancer cells via targeting WWOX regulation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(5): 548-554.
|
[13] |
LUN Wenhui, LI Tiegang, MAO Chun, LYU Jiachun.
Trend analysis and prediction of lung cancer mortality and incidence in urban areas of Guangzhou
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 51-56.
|
[14] |
WANG Qinghua, CAI Hongjian, YUAN Rongzheng, GUAN Jie, GAO Jixu.
Analysis of risk factors of postoperative pulmonary infection in patients with lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 95-99.
|
[15] |
GUO Jing, WANG Youjun, CHU Huisong, QU Jie, ZHAO Ruhan, ZHOU Xin, LYU Xiying.
Relationship between system immune-inflammation index
and prognosis of advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 508-512.
|